A Fusion of Vision, Innovation, and Expertise
From Academic Collaboration to Oncology Innovation: The Founding of IMAI
A
OUR STORY
The beginning of IMAI can be traced back to Francesca Catto's collaboration during her Ph.D. at the Aguzzi Laboratory with Stephan Fox, a product development and mechanical engineering specialist at ETH. Their innovative efforts were later strengthened by Robert Axelrod during his PhD at the Mathys lab, and by Sascha Brun, who joined the project during his master's studies under Fox's guidance. Officially founded in 2024 by Robert, Francesca, and Sascha, IMAI welcomed Martina and Beda to the team, furthering its mission to revolutionize cancer diagnostics through the application of 3D histology.
B
Mission
IMAI is on a mission to redefine the landscape of oncology diagnostics through its pioneering 3D histology technology. By focusing on the early and accurate diagnosis of cancer, IMAI aims to enhance therapeutic outcomes and significantly improve patient care.
C
Vision
Envisioning a future in which its cutting-edge histology technology becomes a cornerstone of clinical practice, IMAI is committed to transforming the approach to cancer diagnosis. This vision includes early stage diagnosis and a deeper understanding of cancer mechanisms, which will lead to optimized treatment plans and better outcomes for patients worldwide.
Meet the Visionaries Behind IMAI
United by a shared passion for transforming patient care and a commitment to excellence, our team combines diverse expertise in biomedicine, engineering, software development, and research. Each member brings a unique set of skills and experiences, driving IMAI towards new frontiers in medical technology.
Meet the Advisors
Behind IMAI is a distinguished panel of advisors, each a luminary in their respective fields. From the intricacies of neuropathology to the frontiers of engineering and the depths of food, nutrition, and health sciences, our advisors bring a wealth of knowledge, experience, and strategic insight.
Prof. Dr. med. Adriano Aguzzi
Head of Scientific advisory board. Director of Neuropathology at University hospital Zurich
Dr. med. Daniel Kirschenbaum
MD PhD Consultant neuropathologist, University Hospital Zurich
Dr. Stephan Fox
Lead Engineering at Feasibility LAB, ETH Zürich
Prof. Dr. Mirko Meboldt
Head of Faculty Conference / Head of CAS ETH Applied Manufacturing Technology. / Deputy Head of Institute for Machine Tools and Manufacturing. ETH Zürich
Prof. Dr. Alexander Mathys
Associate Professor at the Department of Health Sciences and Technology
